Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma
- PMID: 15181575
- DOI: 10.1086/420886
Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma
Abstract
Background: Hodgkin lymphoma (HL) tumors that contain the Epstein-Barr virus (EBV) genome may differ etiologically from EBV-negative HL tumors.
Methods: A case-case study examining heterogeneity of risk factors between disease subgroups compared personal characteristics and EBV antibodies between 95 EBV-positive and 303 EBV-negative patients with HL.
Results: We confirmed previous associations of EBV-positive HL with older age, male sex, and mixed-cellularity (MC) histological subtypes. EBV-positive patients were less educated and more likely to have smoked cigarettes and had more prevalent and higher EBV antibody titers, compared with EBV-negative patients. After adjustment for all independent risk factors, those most strongly associated with EBV-positive HL were histological subtypes (odds ratio [OR] for MC vs. nodular sclerosis histology, 3.2; 95% confidence interval [CI], 1.4-7.2), elevated anti-viral capsid antigen level (OR, 3.1; 95% CI, 1.6-6.0), and less education (OR, 0.7; 95% CI, 0.5-1.0). Cigarette smoking and a low anti-Epstein-Barr nuclear protein (EBNA) 1 : anti-EBNA-2 ratio were also marginally associated with EBV-positive HL.
Conclusions: EBV-positive HL is more common among individuals who have markers of diminished cellular immunity and an abnormal EBV antibody response. EBV appears to participate in the etiology of EBV-positive HL but may not be involved in EBV-negative HL.
Similar articles
-
Cigarette smoking and risk of Hodgkin lymphoma: a population-based case-control study.Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1561-6. doi: 10.1158/1055-9965.EPI-07-0094. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17684129
-
Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.APMIS. 2011 Jan;119(1):10-6. doi: 10.1111/j.1600-0463.2010.02685.x. Epub 2010 Oct 25. APMIS. 2011. PMID: 21143522
-
Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.Clin Cancer Res. 2006 Jan 15;12(2):460-4. doi: 10.1158/1078-0432.CCR-05-2008. Clin Cancer Res. 2006. PMID: 16428487
-
Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.J Clin Oncol. 2005 Oct 20;23(30):7604-13. doi: 10.1200/JCO.2005.02.6310. Epub 2005 Sep 26. J Clin Oncol. 2005. PMID: 16186595 Review.
-
Epstein-Barr virus-associated Hodgkin's lymphoma.Br J Haematol. 2004 May;125(3):267-81. doi: 10.1111/j.1365-2141.2004.04902.x. Br J Haematol. 2004. PMID: 15086409 Review.
Cited by
-
Comparative Analysis of the Humoral Immune Response to the EBV Proteome across EBV-Related Malignancies.Cancer Epidemiol Biomarkers Prev. 2023 May 1;32(5):687-696. doi: 10.1158/1055-9965.EPI-22-0452. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 36788424 Free PMC article.
-
Evidence of EBV infection in lymphomas diagnosed in Lusaka, Zambia.Pan Afr Med J. 2018 Mar 28;29:181. doi: 10.11604/pamj.2018.29.181.11847. eCollection 2018. Pan Afr Med J. 2018. PMID: 30061959 Free PMC article.
-
Frequency of EBV associated classical Hodgkin lymphoma decreases over a 54-year period in a Brazilian population.Sci Rep. 2018 Jan 30;8(1):1849. doi: 10.1038/s41598-018-20133-6. Sci Rep. 2018. PMID: 29382865 Free PMC article.
-
Dietary pattern and risk of hodgkin lymphoma in a population-based case-control study.Am J Epidemiol. 2015 Sep 1;182(5):405-16. doi: 10.1093/aje/kwv072. Epub 2015 Jul 15. Am J Epidemiol. 2015. PMID: 26182945 Free PMC article.
-
Hodgkin lymphoma incidence in ethnic enclaves in California.Leuk Lymphoma. 2015;56(12):3270-80. doi: 10.3109/10428194.2015.1026815. Epub 2015 Jun 18. Leuk Lymphoma. 2015. PMID: 25899402 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical